Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Down 5.1% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Chemours Company (The)?

Chemours Company (NYSE: CC) operates in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The stock sentiment has been a mix of positive and negative lately.

Why is Chemours Company (The) going down?

CC stock is down 5.1% on Mar 30, 2026 19:51

  • Despite a recent 5-day winning streak and reaching a new 52-week high, Chemours stock showed strong bearish movement today.
  • Investor profit-taking following the stock's surge in the past few days could explain the bearish pullback.
  • Concerns from analysts regarding the company's weak operational performance, financial state, and high valuation might have influenced the bearish sentiment.
  • The absence of specific positive developments today likely prompted investors to reassess their positions, resulting in the bearish market trend.

CC Price Chart

CC Technical Analysis

CC News

(CC) and the Role of Price-Sensitive Allocations

This article provides an in-depth analysis of The Chemours Company (NYSE: CC), highlighting strong sentiment across all horizons and presenting specific institutional trading strategies. It details a mid-channel oscillation pattern, an exceptional risk-reward short setup, and AI-generated signals for various timeframes. The analysis includes price targets, stop losses, and support/resistance levels to optimize trading decisions.

https://news.stocktradersdaily.com/news_release/78/CC_and_the_Role_of_Price-Sensitive_Allocations_032826111802_1774754282.html

0 News Article Image (CC) and the Role of Price-Sensitive Allocations

Chemours Stock 5-Day Winning Spree: Stock Climbs 22%

The article reports that Chemours stock has experienced a significant 5-day winning streak, resulting in a 22% climb in its stock price. No further details about the reasons for this performance or specific financial data are provided in the snippet.

https://www.trefis.com/data/companies/CC/no-login-required/rYKeTyDy/Chemours-Stock-5-Day-Winning-Spree-Stock-Climbs-22-

1 News Article Image Chemours Stock 5-Day Winning Spree: Stock Climbs 22%

Chemours Stock Rockets 22% With 5-Day Winning Streak

Chemours (CC) stock has experienced a 22% surge over a 5-day winning streak, increasing its market cap by $587 million to $3.3 billion. Despite this recent rally, Trefis analysts describe the stock as "Very Unattractive" due to its "Very Weak" operating performance, financial condition, and "High valuation." The article emphasizes that such market moves are already priced in, and investors should look for predictive signals rather than reacting to past news.

https://www.trefis.com/articles/595110/chemours-stock-rockets-22-with-5-day-winning-streak/2026-03-28

2 News Article Image Chemours Stock Rockets 22% With 5-Day Winning Streak

Chemours (NYSE:CC) Reaches New 1-Year High - Still a Buy?

Chemours (NYSE:CC) recently hit a new 52-week high of $21.86, trading at $21.85 with a market capitalization of $3.22 billion. Analyst sentiment is mixed, with an average "Hold" rating and a mean price target of $18.40 despite recent target increases. The company surpassed its quarterly EPS expectations, reporting $0.05 against an estimated $0.01, though revenue was down 2.2% year-over-year.

https://www.marketbeat.com/instant-alerts/chemours-nysecc-reaches-new-1-year-high-still-a-buy-2026-03-27/

3 News Article Image Chemours (NYSE:CC) Reaches New 1-Year High - Still a Buy?

CC SEC Filings - Chemours Co 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for investors to access official regulatory documents for Chemours Co (CC), including 10-K, 10-Q, 8-K forms, and insider trading reports, along with AI-generated summaries. It details Chemours' operations across its Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials businesses, highlighting key financial data, strategic priorities, and legal matters such as environmental settlements. The platform aims to help users quickly review regulatory history and track significant corporate events.

https://www.stocktitan.net/sec-filings/CC/page-5.html

4 News Article Image CC SEC Filings - Chemours Co 10-K, 10-Q, 8-K Forms

Chemours Company (The) Price History

30.02.2026 - CC Stock was down 5.1%

  • Despite a recent 5-day winning streak and reaching a new 52-week high, Chemours stock showed strong bearish movement today.
  • Investor profit-taking following the stock's surge in the past few days could explain the bearish pullback.
  • Concerns from analysts regarding the company's weak operational performance, financial state, and high valuation might have influenced the bearish sentiment.
  • The absence of specific positive developments today likely prompted investors to reassess their positions, resulting in the bearish market trend.

20.02.2026 - CC Stock was down 5.0%

  • Today's downward trend in CC's stock price could be linked to an investigation initiated by the Portnoy Law Firm into potential securities fraud, triggered by disappointing financial results in Q4 and full-year 2025. This development possibly eroded investor confidence, resulting in the stock decline.
  • The Brunswick County Board of Commissioners' unanimous disapproval of Chemours' proposed expansion due to worries about PFAS contamination in the Cape Fear River watershed might have exacerbated negative investor sentiment, contributing to the bearish movement.
  • Despite the adverse updates, the recent intraday stock price increase of 7.65% and a subsequent 9.4% rise following analysts' heightened price targets indicate some positive market sentiment. Nevertheless, enduring challenges like a high debt-to-equity ratio and negative return on equity are persisting factors impacting the stock's performance.

19.02.2026 - CC Stock was down 5.6%

  • Today's significant bearish movement in CC's stock might be related to investors having a negative reaction towards the company's cautious capital allocation approach. This was highlighted by a debt refinance with higher coupon rates, an increase in CEO pay, and a dividend cut.
  • Concerns have been raised among investors due to long-term challenges like a high debt-to-equity ratio and negative return on equity, which could have led to the stock sell-off.
  • Although there has been positive short-term performance and an earnings beat as of late, investor sentiment may be impacted by ongoing PFAS liabilities and market risks, ultimately contributing to today's bearish market movement.

05.02.2026 - CC Stock was down 5.4%

  • Analysts have raised their price targets for Chemours, showing optimism and positive expectations for the stock.
  • An investigation into potential claims against Chemours following a stock price decrease due to a one-time inventory charge may have impacted the bearish movement.
  • Reports of an executive receiving restricted stock units (RSUs) and shares being held for tax purposes might have also influenced investor sentiment.
  • The contrasting information of price target increases and investigations into financial disclosures likely caused uncertainty and contributed to the downward trend in Chemours' market performance today.

26.02.2026 - CC Stock was up 5.1%

  • Chemours' stock price surged by 10.11% following the completion of a successful debt swap, indicating investor confidence in the company's financial stability and growth prospects.
  • The strategic agreement with SRF Limited to boost the supply of key low GWP products highlights Chemours' commitment to sustainability and meeting market demand, which likely contributed to the positive market sentiment.
  • Despite facing challenges such as high debt levels and legal battles, Chemours' focus on next-generation refrigerants and environmental regulations positions it well for future growth in the chemical industry.
  • The company's engagement in STEM education initiatives showcases its dedication to fostering talent and innovation, creating a positive image that resonates with investors and stakeholders.

17.02.2026 - CC Stock was up 7.5%

  • Reasons for the recent strong stock performance of Chemours include:
  • Reduction of 77.6% in Cinctive Capital Management LP's stake, signaling a shift in positions.
  • Successful completion of a $700 million private offering of senior unsecured notes due 2034, bolstering investor trust in the company's financial structure.
  • Despite worries about PFAS liabilities and market risks, the company exceeded Q3 earnings expectations with $1.33 billion in revenue and maintained a quarterly dividend, painting a positive picture for investors.
  • Discordant fair value assessments and differing opinions on the company's actual value may have led to stock price volatility, prompting today's upward movement as investors reevaluate their positions in light of the latest developments.

17.02.2026 - CC Stock was up 6.0%

  • Chemours opted to refinance existing debt through the issuance of $700 million in senior unsecured notes due 2034. Despite a higher coupon rate, extended maturities, and a dividend cut, this move reflects a prudent capital allocation strategy amidst ongoing PFAS liabilities and market risks.
  • The disparity in fair value signals for the stock adds to investor uncertainty. While a DCF model indicates an undervaluation at $49.99, a different valuation pegs it at $16.33, creating the need for thorough due diligence.
  • Wolf Hill Capital Management LP's recent acquisition of a stake in Chemours, combined with positive Q3 earnings and a consensus "Hold" rating from analysts, has fueled market optimism. Investors seem confident in the company's potential for future growth.
  • The successful completion of a private offering for $700 million in senior unsecured notes due 2034, aimed at optimizing the balance sheet by refinancing existing obligations and funding note redemptions, has further buoyed investor sentiment and propelled the stock's upward trajectory.

25.02.2026 - CC Stock was up 5.1%

  • A successful $700 million debt refinancing and insider buying activities have eased financial concerns, fostering a favorable investor sentiment.
  • Price target upgrades from various firms, including UBS and Mizuho, have been influenced by robust quarterly earnings within the specialized solutions segment, contributing to the uptrend in the stock.
  • Despite potential challenges like regulatory scrutiny regarding environmental issues such as PFAS liabilities, Chemours' strategic outlook remains promising due to continuous innovation efforts and substantial order backlogs.
  • An investigation by The Portnoy Law Firm subsequent to disappointing Q4 and full-year 2025 financial results may have initially dampened investor confidence; however, positive developments thereafter appear to have reversed the stock's trajectory.

24.02.2026 - CC Stock was up 6.1%

  • The bullish movement in CC's stock can be attributed to the successful $700 million private sale of senior notes and insider buying, which helped alleviate financial concerns and boost investor confidence.
  • Analyst upgrades and positive outlook on the company's strategic direction, particularly in the thermal and specialized solutions segment, have also contributed to the stock surge.
  • Despite ongoing legal challenges and environmental controversies, including the lawsuit against DuPont and Chemours and opposition to the Fayetteville expansion, the market seems to be focusing more on the company-specific improvements and growth prospects, leading to the bullish momentum in CC's stock.

23.02.2026 - CC Stock was up 5.0%

  • The North Carolina Supreme Court reviewing a lawsuit against DuPont and Chemours may have introduced legal uncertainties and risks for the company, impacting market sentiment initially.
  • An investigation into potential securities fraud by the Portnoy Law Firm following disappointing financial results likely contributed to CC's stock price decline.
  • The subsequent increase in CC's stock price may be linked to three analyst firms raising their price targets for the company, indicating improved sentiment and potentially attracting more institutional investors.
  • The strong intraday surge and outperformance of the S&P 500 suggest a positive short-term market response to the raised price targets and overall analyst enthusiasm, despite CC's enduring financial challenges and environmental issues.

10.02.2026 - CC Stock was up 7.1%

  • Factors contributing to CC's stock price surge include:
  • A strong earnings per share (EPS) beat and the company's announcement of a quarterly dividend, potentially boosting investor confidence.
  • Despite encountering obstacles like a one-time inventory charge and short-term market challenges, the stock demonstrated resilience and attracted new institutional investors.
  • Positive technical indicators hinting at a bullish to mildly bullish trend for the stock likely heightened traders' optimism.
  • Despite initial uncertainties surrounding an investigation, investors appear positive about CC's future prospects based on the stock's performance.

09.02.2026 - CC Stock was up 5.0%

  • An inquiry triggered by a specific firm in response to the stock price drop may have rattled investors initially, yet subsequent market activity indicates a more positive investor sentiment.
  • The increased institutional investments from Neo Ivy Capital Management and American Century Companies Inc. signal a growing belief in Chemours' long-term prospects, despite varied analyst evaluations and recent downward revisions in earnings forecasts.
  • Chemours' adoption of Adobe Marketo Engage to enhance marketing outcomes demonstrates a commitment to expansion and customer interaction, potentially contributing to the recent positive market trends.
  • While short-term hurdles may have affected Chemours' stock value, the company's strategic efforts and investor trust appear to be propelling the recent market upswing.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.